Bridgeworth’s Sanofi SNY Stock Holding History

Bridgeworth’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-953	Closed	-$38K	–	474
2018 Q2	$38K	Buy	+953	New	+$37.5K	0.02%	317

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Bridgeworth's SNY Position: Q3 2018 in Review

Bridgeworth sold out of Sanofi (SNY) in Q3 2018, closing a stake of 953 shares — an estimated $38K sold.

Bridgeworth first reported a position in SNY in Q2 2018 and held it in 1 quarter. The position peaked at $38K in Q2 2018. 480 funds tracked by Wall St. Rank hold SNY as of Q3 2018.

Bridgeworth reported no remaining Sanofi position as of Q3 2018 after selling out during the quarter.
Bridgeworth sold 953 Sanofi shares in Q3 2018, an estimated $38K.
Bridgeworth first reported a position in Sanofi in Q2 2018 and held it in 1 quarter.
Bridgeworth's Sanofi position peaked at $38K in Q2 2018.
480 funds tracked by Wall St. Rank held Sanofi as of Q3 2018.

Based on Bridgeworth's 13F filing for Q3 2018, filed 13 Nov 2018.